Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)

This study has been completed.
Sponsor:
Collaborator:
Beijing Anzhen Hospital
Information provided by:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
ClinicalTrials.gov Identifier:
NCT00817024
First received: January 4, 2009
Last updated: May 31, 2012
Last verified: January 2009